Clinical Chemistry Analyzers Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)

The Clinical Chemistry Analyzers Market is Segmented by Product Type (Analyzers, Reagents, and Others), Types of Test, End User, and Geography.

Clinical Chemistry Analyzers Market Snapshot

Clinical Chemistry Analyzers Market 1
Study Period: 2018 - 2026
Base Year: 2020
Fastest Growing Market: Europe
Largest Market: North America
CAGR: 5.9 %

Need a report that reflects how COVID-19 has impacted this market and its growth?

Market Overview

The major factors for the growth of the clinical chemistry analyzers market include the rising geriatric population and increasing prevalence of chronic diseases, increasing importance and awareness of point-of-care testing, and rising technological advancements in clinical chemistry analyzer.

The clinical chemistry analyzers run assays on clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to disease or drugs. The major factor driving the growth of the market includes rising geriatric population and increasing prevalence of chronic diseases. According to the United States Census Bureau’s Statistics, as of 2017, the total number of people aged 65 years and older exceeded 50 million, and between 2020 and 2030, the number of elderly people is projected to increase by almost 18 million. Although much smaller in total size, the number of people aged 85 years and older is expected to more than triple from an estimated 6 million, in the present scenario, to nearly 20 million by 2060. The rising geriatric population will lead to an increase in various diseases resulting in the high demand for clinical tests. Thus, the clinical chemistry analyzers market is expected to witness high growth over the forecast period.

Scope of the Report

As per the scope of this report, clinical chemistry analyzers run assays on clinical samples such as blood, plasma, urine, and cerebrospinal fluid in order to detect the presence of analytes relating to disease or drugs. The Clinical Chemistry Analyzers market is segmented by product type, types of test, end user, and geography.

By Product Type
Analyzers
Reagents
Others
By Types of Test
Liver Panels
Electrolyte Panels
Thyroid Function Panels
Lipid Profiles
Others
By End User
Hospital
Diagnostic Laboratories
Academic Institutes
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle-East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

Key Market Trends

Analyzers in Product Type Segment are Expected to Witness Fastest Growth over the Forecast Period

The analyzers are the instruments which analyze the sample such as blood serum and urine. The clinical chemistry analyzers are witnessing high growth owing to the rising technological advancements in the instruments. The market players are focusing on providing cost-effective equipment to end-user. The automation has become pervasive in clinical laboratories around the world. In order to reduce the healthcare costs, laboratories have relied on automation to maintain profitability as well.

Furthermore, in November 2018, the Primary Health Care has joined forces with Siemens Healthineers to deploy more than 70 Atellica Solution immunoassay and clinical chemistry analyzers. Thus, the rising technological advancements in the analyzers expected to propel the overall growth of the Clinical Chemistry Analyzers market.

Clinical Chemistry Analyzer Market Trend.png

North America is Expected to Dominate the Market

According to the Centers for Disease Control and Prevention, chronic diseases were the leading cause of death and disability in the United States. In addition, rising healthcare expenditure, along with the rapid adoption of point-of-care testing, is expected to boost the growth of the market. The major market players are launching new technologically advanced products in the market. For instance, recently in September 2019, one of the major market player Siemens Healthineers announced the global commercial availability of its Atellica Solution automation-ready immunoassay and chemistry analyzers and DynLife ( healthcare facility in Canada) was the first to adopt this solution. Thus, owing to the all above-mentioned factors North America is expected to hold largest share in the Clinical Chemistry Analyzers Market.

Clinical Chemistry Analyzer Market - Growth Rate by Region

Competitive Landscape

The market studied is a fragmented market owing to the presence of various market players. Some of the market players are Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), Elitech Group, F.Hoffmann-La Roche Ltd., Horiba, Ltd., Johnson & Johnson, Mindray Medical International Limited, Siemens Healthcare Private Limited, Sysmex Corporation, and Thermo Fisher Scientific Inc.

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Deliverables

    2. 1.2 Study Assumptions

    3. 1.3 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Rising Geriatric Population and Increasing Prevalence of Chronic Diseases

      2. 4.2.2 Increasing Importance and Awareness of Point-of-care Testing

      3. 4.2.3 Rising Technological Advancements in Clinical Chemistry Analyzer

    3. 4.3 Market Restraints

      1. 4.3.1 Lack of Trained and Qualified Professionals

      2. 4.3.2 High Cost

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product Type

      1. 5.1.1 Analyzers

      2. 5.1.2 Reagents

      3. 5.1.3 Others

    2. 5.2 By Types of Test

      1. 5.2.1 Liver Panels

      2. 5.2.2 Electrolyte Panels

      3. 5.2.3 Thyroid Function Panels

      4. 5.2.4 Lipid Profiles

      5. 5.2.5 Others

    3. 5.3 By End User

      1. 5.3.1 Hospital

      2. 5.3.2 Diagnostic Laboratories

      3. 5.3.3 Academic Institutes

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle-East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Abbott Laboratories

      2. 6.1.2 Danaher Corporation (Beckman Coulter, Inc.)

      3. 6.1.3 Elitech Group

      4. 6.1.4 F. Hoffmann-La Roche Ltd.

      5. 6.1.5 Horiba, Ltd.

      6. 6.1.6 Johnson & Johnson

      7. 6.1.7 Mindray Medical International Limited

      8. 6.1.8 Siemens Healthcare Private Limited

      9. 6.1.9 Sysmex Corporation

      10. 6.1.10 Thermo Fisher Scientific Inc.

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Clinical Chemistry Analyzers Market market is studied from 2018 - 2026.

The Clinical Chemistry Analyzers Market is growing at a CAGR of 5.9% over the next 5 years.

Europe is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2020.

Abbott Laboratories, Danaher Corporation (Beckman Coulter, Inc.), Mindray Medical International Limited, Siemens Healthcare Private Limited, Thermo Fisher Scientific Inc. are the major companies operating in Clinical Chemistry Analyzers Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!